Brown Advisory’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-399,637
Closed -$15.8M 1262
2022
Q4
$15.8M Sell
399,637
-244,208
-38% -$10.2M 0.03% 345
2022
Q3
$30M Buy
643,845
+6,447
+1% +$299K 0.06% 245
2022
Q2
$27.9M Buy
637,398
+2,453
+0.4% +$135K 0.05% 263
2022
Q1
$45.9M Buy
634,945
+110,833
+21% +$7.99M 0.07% 212
2021
Q4
$42.5M Buy
524,112
+156,109
+42% +$15.6M 0.05% 234
2021
Q3
$42.8M Buy
368,003
+30,203
+9% +$3.95M 0.06% 210
2021
Q2
$56M Buy
337,800
+18,845
+6% +$2.94M 0.08% 182
2021
Q1
$44.5M Buy
318,955
+87,967
+38% +$14.4M 0.08% 193
2020
Q4
$40M Buy
230,988
+8,925
+4% +$1.45M 0.07% 188
2020
Q3
$30.9M Buy
222,063
+1,605
+0.7% +$214K 0.06% 191
2020
Q2
$26.3M Buy
+220,458
New +$26.1M 0.06% 200

Other funds holding NVRO

Brown Advisory's NVRO Position: Q1 2023 in Review

Brown Advisory sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 399,637 shares — an estimated $15.8M sold.

Brown Advisory first reported a position in NVRO in Q2 2020 and held it in 11 quarters. The position peaked at $56M in Q2 2021. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

  • Brown Advisory reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
  • Brown Advisory sold 399,637 NEVRO CORP. shares in Q1 2023, an estimated $15.8M.
  • Brown Advisory first reported a position in NEVRO CORP. in Q2 2020 and held it in 11 quarters.
  • Brown Advisory's NEVRO CORP. position peaked at $56M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Brown Advisory's 13F filing for Q1 2023, filed 8 May 2023.